Nimbus Therapeutics Appoints Peter J. Tummino, Ph.D. as President of Research and Development
Position
President
Company
Nimbus Therapeutics
BostonBiotechnologyHealth CareTherapeuticsPharmaceuticalDescription
Nimbus Therapeutics announced the advancement of its clinical oncology therapeutic pipeline and the appointment of Peter J. Tummino, Ph.D., to President of Research and Development.
Quick answer
Nimbus Therapeutics Appoints Peter J. Tummino, Ph.D. as President of Research and Development (January 9, 2025). Nimbus Therapeutics is based in Boston, Massachusetts, United States.
- Who is the new President at Nimbus Therapeutics?
- Nimbus Therapeutics named Peter J. Tummino President, announced January 9, 2025.
- What did Nimbus Therapeutics announce on January 9, 2025?
- Nimbus Therapeutics announced the advancement of its clinical oncology therapeutic pipeline and the appointment of Peter J. Tummino, Ph.D., to President of Research and Development.
- What does Nimbus Therapeutics do?
- Nimbus Therapeutics, LLC is a biotechnology company that designs and develops breakthrough medicines for patients through its powerful computational drug discovery engine.
- Where is Nimbus Therapeutics based?
- Nimbus Therapeutics is based in Boston, Massachusetts, United States.
- Which similar companies made leadership changes around the same time?
- Centessa Pharmaceuticals plc (January 8, 2025), Tarsier Pharma (January 7, 2025), Amylyx Pharmaceuticals (January 6, 2025) and Oragenics (January 17, 2025) also announced leadership changes within 45 days of Nimbus Therapeutics.
Source: Fundz verified event record.
Other recent leadership changes in Therapeutics and Pharmaceutical
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Centessa Pharmaceuticals plc Appoints Stephen Kanes MD PhD as Chief Medical Officer (January 8, 2025)
- Tarsier Pharma Appoints Ashley Kline as Chief Commercial Officer (January 7, 2025)
- Amylyx Pharmaceuticals Appoints Dan Monahan as Chief Commercial Officer (January 6, 2025)
- Oragenics Appoints Janet Huffman as Interim Chief Executive Officer (January 17, 2025)
- Arcus Biosciences Appoints Richard Markus, M.D., Ph.D., as Chief Medical Officer (January 21, 2025)
- Nurix Therapeutics appoints John Northcott as Chief Commercial Officer (January 22, 2025)
Who to call at Nimbus Therapeutics, and when
A new leader at Nimbus Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Nimbus Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Nimbus Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Nimbus Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Nimbus Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Nimbus Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.